Research News
View articles by month and year
-
Measuring Levels of Specific Protein Doesn’t Help Decide Who Benefits from Chemotherapy
Measuring the Ki-67 protein in breast cancers doesn't help decide who would benefit from chemotherapy in women diagnosed with hormone-receptor-positive, node-negative disease.
-
Digital Mammograms Better Than Film for Younger Women
Digital mammograms are more accurate in finding breast cancer than film mammograms for women who are younger than 50, have dense breasts, or who still have their periods (or have had a period within the past year).
-
Women Less Likely to Get Mammogram with Copay, Even If It’s Small
Requiring a co-pay for screening mammograms -- even a small amount -- cuts the likelihood that women will get regular mammograms.
-
African American Women Less Likely to Get BRCA Testing
African American women are less likely than white women to be tested for an abnormal BRCA1 or BRCA2 gene.
-
Simple Saliva Test May Detect Breast Cancer
Researchers are working to create a breast cancer screening test that uses saliva proteins to detect cancers.
-
Genetic Test Can Predict Recurrence Risk, Help Make Treatment Decisions
The Oncotype DX test can help determine who will benefit from hormonal therapy plus chemotherapy, as opposed to hormonal therapy alone, in post-menopausal women diagnosed with estrogen-receptor-positive, node-positive breast cancer.
-
Radiologists Interpret Mammograms Differently
The ability of radiologists to accurately read diagnostic mammograms varies widely and radiologists who work at academic medical centers are likely to be more accurate than non-medical center radiologists.
-
Stereoscopic Digital Mammography Halves False-Positive Rate
Stereoscopic digital mammography can reduce the number of false positive mammogram results. But the technique is very new and not widely available yet.
-
High White Blood Cell Count May Increase Risk
Higher than average white blood cell counts may offer doctors another way to evaluate cancer risk.
-
Measuring Circulating Tumor Cells May Help Determine Recurrence Risk
A test that measures circulating tumor cells in the blood may help doctors more accurately determine the risk of breast cancer recurrence.
